Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Eschenauer

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The Annals of Pharmacotherapy|June 25, 2015
Is Fluconazole or an Echinocandin the Agent of Choice for CandidemiaGregory A Eschenauer, Minh-Hong Nguyen, Cornelius J Clancy
Journal of Clinical Microbiology|August 24, 2018
Are <i>In Vitro</i> Susceptibilities to Azole Antifungals Predictive of Clinical Outcome in the Treatment of Candidemia?Twisha S Patel, Peggy L Carver, Gregory A Eschenauer
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 31, 2009
Antifungal prophylaxis in liver transplant recipientsGregory A Eschenauer, Simon W Lam, Peggy L Carver
The New England Journal of Medicine|May 26, 2006
Antibiotic allergyGregory A Eschenauer, Randolph E Regal, Daryl D DePestel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2023
Zinc and Coronavirus Disease 2019Susan Swindells, Gregory A Eschenauer, Martha Nason, et al.
Journal of Clinical Microbiology|April 6, 2007
To test or not to test: a cost minimization analysis of susceptibility testing for patients with documented Candida glabrata fungemiasCurtis D Collins, Gregory A Eschenauer, Susan L Salo, et al.
Transplantation|March 8, 2016
Antifungal Prophylaxis in Lung Transplant RecipientsTwisha S Patel, Gregory A Eschenauer, Linda J Stuckey, et al.
Medical Mycology|February 10, 2010
The impact of delaying the initiation of appropriate antifungal treatment for Candida bloodstream infectionMaabo Kludze-Forson, Gregory A Eschenauer, Christine J Kubin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Calming the "perfect storm" in methicillin-resistant Staphylococcus aureus bacteremia: a call for a more balanced discussionGregory A Eschenauer, Jerod L Nagel, Christine J Kubin, et al.
Diagnostic Microbiology and Infectious Disease|April 2, 2010
Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomesMay Nguyen, Gregory A Eschenauer, Monique Bryan, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Annals of Pharmacotherapy|June 25, 2015
Is Fluconazole or an Echinocandin the Agent of Choice for CandidemiaGregory A Eschenauer, Minh-Hong Nguyen, Cornelius J Clancy
Journal of Clinical Microbiology|August 24, 2018
Are <i>In Vitro</i> Susceptibilities to Azole Antifungals Predictive of Clinical Outcome in the Treatment of Candidemia?Twisha S Patel, Peggy L Carver, Gregory A Eschenauer
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 31, 2009
Antifungal prophylaxis in liver transplant recipientsGregory A Eschenauer, Simon W Lam, Peggy L Carver
The New England Journal of Medicine|May 26, 2006
Antibiotic allergyGregory A Eschenauer, Randolph E Regal, Daryl D DePestel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2023
Zinc and Coronavirus Disease 2019Susan Swindells, Gregory A Eschenauer, Martha Nason, et al.
Journal of Clinical Microbiology|April 6, 2007
To test or not to test: a cost minimization analysis of susceptibility testing for patients with documented Candida glabrata fungemiasCurtis D Collins, Gregory A Eschenauer, Susan L Salo, et al.
Transplantation|March 8, 2016
Antifungal Prophylaxis in Lung Transplant RecipientsTwisha S Patel, Gregory A Eschenauer, Linda J Stuckey, et al.
Medical Mycology|February 10, 2010
The impact of delaying the initiation of appropriate antifungal treatment for Candida bloodstream infectionMaabo Kludze-Forson, Gregory A Eschenauer, Christine J Kubin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Calming the "perfect storm" in methicillin-resistant Staphylococcus aureus bacteremia: a call for a more balanced discussionGregory A Eschenauer, Jerod L Nagel, Christine J Kubin, et al.
Diagnostic Microbiology and Infectious Disease|April 2, 2010
Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomesMay Nguyen, Gregory A Eschenauer, Monique Bryan, et al.
Pageof 4